HAI Book 2025 - Flipbook - Page 459
Thursday, January 16, 2025 - 02:25 pm - 03:50 pm
Podium Session
SESSION V: Clinically Relevant Applications
CHAIRS: Renaud La Joie, Reisa Sperling
Thursday, January 16, 2025
SESSION V
02:25 pm - 03:50 pm
Clinically Relevant Application
Renaud La Joie, University of California,
San Francisco, San Francisco, CA, USA
Reisa Sperling, Brigham and Women's
Hospital/HMS, Boston, MA, USA
02:25 pm - 02:30 pm Session Overview
Chairs
Neuropathologic and ARIA-related findings
in aducanumab-treated Alzheimer's disease:
02:30 pm
a postmortem analysis of superficial cortical
A´ clearance
Baayla D.C. Boon, Department of
Neuroscience, Jacksonville, FL, US
Robustness of the centiloid scale across
02:45 pm research and commercial software using
[18F]flutemetamol PET images
Adam Schwarz, GE HealthCare,
Chalfont St. Giles, GB
03:00 pm
Impact of ARIA on cerebral volume changes
with Gantenerumab
Independent effects of baseline white
03:15 pm matter hyperintensity and APOE ɛ4 on future
ARIA-H emergence in A4 trial
03:30 pm – 3:50 pm Discussion
HAI2025 - 459
Matteo Tonietto, Research and Early
Development (pRED), Hoffmann-La
Roche, Basel, CH
Zahra Shirzadi, Department of
Neurology, Massachusetts General
Hospital, Brigham and Women's
Hospital, Harvard Medical School,
Boston, MA, US
